A Phase II Randomized Crossover Study of Liposomal Doxorubicin Versus Weekly Docetaxel in the First-line Treatment of Women With Metastatic Breast Cancer
Titel:
A Phase II Randomized Crossover Study of Liposomal Doxorubicin Versus Weekly Docetaxel in the First-line Treatment of Women With Metastatic Breast Cancer
Auteur:
Yardley, Denise A. Burris III, Howard A. Spigel, David R. Clark, Bobby L. Vazquez, Elizabeth Shipley, Dianna Barton, John Thompson, Dana Montes, Ignacio Greco, F. Anthony Hainsworth, John D.